For example, NR2F2 has been shown to determine hepatoma phenotype by acting both as a transcriptional repressor of microsomal triglyceride transfer protein (MTP) and an inducer of CYP7A1 [43]. This evidence concerns the gene NR2F2 and hepatocellular carcinoma.